Navigation Links
Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million

EATONTOWN, N.J., July 31 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, reported today that net income for the three months ended June 30, 2008 was $1.7 million, or $.10 diluted earnings per share compared to net income of $.9 million, or $.05 diluted earnings per share, for the second quarter of 2007. Revenue for the three months ended June 30, 2008 increased 4% to $27.6 million from $26.5 million for the same period in the prior year. Gross margin was 53% and 48% in the second quarter of 2008 and 2007, respectively. Net income for the three months ended June 30, 2008 included $1.0 million associated with the settlement of certain litigation.

Net income for the six months ended June 30, 2008 was $2.6 million, or $.14 diluted earnings per share, compared to net income of $.2 million, or $.01 diluted earning per share, for the same period in the prior year. Revenue for the six months ended June 30, 2008 increased 7% to $55.2 million from $51.7 million for the six months ended June 30, 2007. Gross margin was 52% for the first half of 2008 compared to 49% for the first half of 2007. Net income for the first half of 2007 was negatively impacted by first quarter costs of $1.1 million related to the settlement of certain litigation.

Sam Owusu-Akyaw, Osteotech's President and Chief Executive Officer, stated, "Our financial performance continues to demonstrate our ability to effectively manage the business. The key initiative for 2008 is distribution effectiveness. The international sales team is taking shape and the domestic sales initiatives, including the focus on master sales agencies, are moving forward."

Mr. Owusu-Akyaw will host a conference call on July 31, 2008 at 9:00 a.m. Eastern Time to discuss second quarter results. You are invited to listen to the conference call by dialing 706-643-1624. The conference will also be simultaneously webcast at Automated playback will be available two hours after completion of the live call, through midnight, Thursday, August 14, 2008, by dialing 706-645-9291 and indicating access code 52377240.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech, this press release or the conference call, please go to Osteotech's website at

Certain statements made throughout this press release that are not historical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company's ability to develop and introduce new products, differences in anticipated and actual product and service introduction dates, the ultimate success of those products in the marketplace, the continued acceptance and growth of current products and services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of July 31, 2008 and the Company does not intend to update this information.

OSTEOTECH, INC. and Subsidiaries


(dollars in thousands, except per share data)

Three Months Six Months

Ended June 30, Ended June 30,

2008 2007 2008 2007

Revenue $27,553 $26,470 $55,184 $51,687

Cost of revenue 13,051 13,680 26,440 26,580

Gross profit 14,502 12,790 28,744 25,107

Marketing, selling and

general and

administrative expenses 11,323 10,434 23,003 22,124

Research and development

expenses 1,774 1,281 3,534 2,445

13,097 11,715 26,537 24,569

Operating income 1,405 1,075 2,207 538

Interest expense, net (274) (152) (486) (302)

Other 945 (114) 1,223 22

Income before income taxes 2,076 809 2,944 258

Income tax provision

(benefit) 330 (46) 390 51

Net Income $1,746 $855 $ 2,554 $207

Earnings per share:

Basic $.10 $.05 $.14 $.01

Diluted $.10 $.05 $.14 $.01

Shares used in computing

earnings per share:

Basic 17,771,799 17,466,368 17,744,656 17,442,969

Diluted 17,919,695 18,009,774 17,904,128 17,912,380


(dollars in thousands)

Three Months Six Month

Ended June 30, Ended June 30,

2008 2007 2008 2007

DBM $16,575 $16,161 $33,541 $31,643

Hybrid/Synthetic 727 408 1,371 641

Traditional Tissue 5,250 4,558 10,360 9,169

Spinal Allografts 2,286 3,221 4,536 6,009

Client Services 2,397 1,944 4,821 3,872

Other Product Lines 318 178 555 353

Revenue $27,553 $26,470 $55,184 $51,687

OSTEOTECH, INC. and Subsidiaries


(dollars in thousands)

June 30, December 31,

2008 2007


Cash and cash equivalents $19,128 $22,777

Accounts receivable, net 23,177 19,353

Deferred processing costs 29,985 30,850

Inventories 1,314 1,171

Prepaid expenses and other current assets 3,971 3,957

Total current assets 77,575 78,108

Property, plant and equipment, net 35,340 34,508

Other assets 12,291 7,735

$125,206 $120,351

Liabilities and Stockholders' Equity

Accounts payable and accrued liabilities $20,554 $19,364

Current maturities of capital lease obligation 850 807

Total current liabilities 21,404 20,171

Capital lease obligation 13,634 14,069

Other liabilities 7,137 7,083

Total liabilities 42,175 41,323

Stockholders' equity 83,031 79,028

$125,206 $120,351

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
2. Osteotech Completes Tissue Supply Agreement With LifeNet Health
3. Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09
5. Osteotech Signs Agreement To Distribute Harvest Technologies BMAC(TM) System
6. Osteotech Engages BioHorizons as Exclusive Distributor to International Dental Market
7. Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
(Date:10/13/2015)... ... , ... Curly Hair Solutions® is thrilled to be a ... featuring the newest products and services to hit the market for women. With ... to unveil their recent partnership with Trade Secrets, a leading Canadian beauty retailer. ...
(Date:10/12/2015)... TN (PRWEB) , ... October 13, 2015 , ... ... recipients of its biannual Heroes in Recovery Awards at Foundations Recovery Network’s Moments ... Recovery Network presented the one-of-a-kind awards to Noah Levine and Dean Dauphinais who ...
(Date:10/12/2015)... ... 12, 2015 , ... According to an article from ... particularly in the area of track and field, are at a significantly higher ... peers in the same age group. Dr. Steven Meier of Meier Orthopedic Sports ...
(Date:10/12/2015)... ... October 12, 2015 , ... American Family Care (AFC), the nation’s ... by opening its 151st medical center. Located at 606A Boll Weevil Circle in Enterprise, ... continue fulfilling our mission of making quality health care accessible and economical with the ...
(Date:10/12/2015)... ROSA, CA (PRWEB) , ... October 12, 2015 , ... ... (DSM) at no charge to qualified Managed Care Organizations (MCOs) in order to ... insight and analysis into their decision making process. In addition, the DSM is also ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... COSTA MESA, Calif. , Oct. 12, 2015 ... reaffirmed the accreditation of Harbor Compounding Pharmacy in ... accreditation is awarded in recognition of the pharmacy,s ... --> ... --> ...
(Date:10/12/2015)... Calif. , Oct. 12, 2015 /PRNewswire/ ... and Chief Scientific Officer of Asterias Biotherapeutics, ... company in the emerging field of regenerative ... webcast, sponsored in part by Asterias Biotherapeutics, ... Lebkowski will discuss the progress to date ...
(Date:10/12/2015)... , Oct. 12, 2015  In a Sutter ... the Journal of Neurology, Neurosurgery, and Psychiatry, the blood ... brain atrophy and cognitive decline in patients in the ... --> --> IVIG, extracted from the ... to amyloid, an abnormal brain protein found in patients ...
Breaking Medicine Technology: